C4 Therapeutics, Inc.

From C4 Therapeutics's results release of 5 Kasım 2026; its quarterly report has since been filed.

• Revenue

  Actual

  $8,5M

  -%25 y/y ↓
  +%28 q/q ↑

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  -$0,16

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  -$24,6M

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.